Abstract:Prediction of conversion from mild cognitive impairment (MCI) to Alzheimer's disease (AD) has attracted significant attention recently. Most investigations have used a single modality of data. In the present study, multiple features from different modalities of data, including structural MRimaging (MRI), cognitive measures (CM) and cerebrospinal fluid (CSF) biomarkers, were examined in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort, in order to establish a set of sensitive predictors and to capture MCI conversion and corresponding conversion time. Based on their follow-up evaluations, MCI subjects at baseline were categorized into two subgroups: MCI converters (MCIc), MCI individuals who developed AD within the 24 months follow-up period, and MCI non-converters (MCInc), MCI individuals who did not developed AD within 24 months. The prediction procedure consisted of three stages: (1) feature extraction and collection; (2) feature selection; and (3) classification. MRI features which had been extracted automatically using FreeSurfer, as well as a set of typical cognitive measures and CSF biomarkers were downloaded from ADNI website. Then mutual information-based feature ranking followed by a wrapper method was employed to select an optimal subset of MRI features and cognitive features. After feature selection, support vector machines were trained using both a single modality and combinations of multiple modalities of features. Note that training was conducted on NC and AD individuals and testing was conducted on MCI individuals. A real predictive value was generated for each test subject using the classifier, which indicated whether the subject was classified as MCIc or MCInc. Selected MRI features were measures of the entorhinal cortex, hippocampus, middle temporal gyrus, inferior parietal cortex and retrosplenial cortex. Selected cognitive assessments included CDR-SOB (Clinical Dementia Rating Scale Sum of Boxes scores), logical memory delayed recall, MMSE (MiniMental State Examination), number cancellation, ADAS (Alzheimer's Disease Assessment Scale-Cognitive subscale) word list delayed recall, FAQ (Functional Assessment Questionnaire), logical memory immediate recall, AVLT (Auditory Verbal Learning Test) delayed recall, clock drawing and ADAS word list immediate recall. The best performance was attained using multiple features, including select cognitive, MRI features and t-tau/Aß 1-42 (ratio of total tau to amyloid-ß 1 to 42 peptide), which achieved 96.43% sensitivity, 35.63% specificity, 59.44% accuracy and an AUC (area under a receiver operating characteristic curve) of 0.7588 by 24months follow-up. The specificity rose from 22.63% at 6 months to 35.63% at 24months. The sensitivities were always above 96% from 6 to 24 months. As a result, the accuracy increased from 25.87% to 59.44%. Predictive values of MCI subjects who converted within 1 year and after 1 year were -0.65±0.26 and-0.39±0.28, respectively, which are significantly different (p > 0.001). Our selected features, obtained using automatic feature selection techniques, correspond with the findings of recent studies. The combination of multiple features including CM, MRI and CSF biomarkers, out performed the use of a single modality of features because the different features selected were mutually complementary. In addition, our classifier was able to predict 1-year conversion time. Taken together, this study establishes multivariate predictive markers which may be practical and helpful for clinical diagnosis.

Clinical classification of memory and cognitive impairment with multimodal digital biomarkers

Classification and Interpretability of Mild Cognitive Impairment Based on Resting-State Functional Magnetic Resonance and Ensemble Learning.

Multimodal Identification of Alzheimer's Disease: A Review

Automated Classification of Cognitive Decline and Probable Alzheimer's Dementia Across Multiple Speech and Language Domains

Multimodality Neuroimaging in Mild Cognitive Impairment: A Cross-sectional Comparison Study

Spoken Language Biomarkers for Detecting Cognitive Impairment

Multimodal prediction of conversion to Alzheimer's disease based on incomplete biomarkers

Multimodal classification of Alzheimer's disease and mild cognitive impairment

Predicting conversion from mild cognitive impairment to Alzheimer's disease: a multimodal approach

Classification of MRI and Psychological Testing Data Based on Support Vector Machine.

Classification and Graphical Analysis of Alzheimer’s Disease and Its Prodromal Stage Using Multimodal Features From Structural, Diffusion, and Functional Neuroimaging Data and the APOE Genotype

Combining Multimodal Behavioral Data of Gait, Speech, and Drawing for Classification of Alzheimer’s Disease and Mild Cognitive Impairment

Tracking Progression from Mild Cognitive Impairment to Alzheimer's Disease Using Multivariate Biomarkers and Pattern Classification

Neural Mechanism Underlying Successful Classification of Amnestic Mild Cognitive Impairment Using Multi-Sensory-Evoked Potentials

Multimodal deep learning for Alzheimer’s disease dementia assessment

Predicting and Characterizing Neurodegenerative Subtypes with Multimodal Neurocognitive Signatures of Social and Cognitive Processes

Improving clinical efficiency in screening for cognitive impairment due to Alzheimer's

may yield important insights into genetic influences on the biology of Alzheimer’s disease (AD).We investigated the accuracy of a novel unsuper- vised multimodal biomarker classifier for differentiating cognitively normal elderly (NC) from subjects with amnestic mild cognitive impairment

A Multi-classification Accessment Framework for Reproducible Evaluation of Multimodal Learning in Alzheimer's Disease

Performance and validation of a digital memory test across the Alzheimer's Disease continuum

Detection of Mild Cognitive Impairment From Non-Semantic, Acoustic Voice Features: The Framingham Heart Study